Shire and Takeda agree £46 billion takeover deal
The board of FTSE 100 drug firm Shire (LON:SHP) has recommended that shareholders accept Takeda’s takeover bid. The offer of…
7 years ago
Latest
The absolute return fund that is shorting Tesla
My colleague, Simon Cawkwell, writing in his Evil Diaries, recently described Tesla (NASDAQ:TSLA) as “surely…..the greatest short in the history of…
7 years ago
Is AIM still “the world’s leading growth market”?
The Alternative Investment Market – also known as “AIM” – provokes controversy in the investment community. Some see it as…
7 years ago
Trumpery is Working!
We always knew that Donald Trump was a badass. What we didn’t know (though the stock markets kind of knew)…
7 years ago
2 FTSE 100 turnaround stocks that could offer high returns
While the FTSE 100 may have gained 7% in the last month to trade within 250 points of its all-time…
7 years ago
The problem with growth
One of the most influential things I have ever seen is a presentation on YouTube. Its formal title is Arithmetic,…
7 years ago
Skin in the game
Recent research by the broker Canaccord Genuity has highlighted which boards of directors and fund managers have the most significant…
7 years ago
A memorable afternoon
Friday afternoon was cold and damp and we had to walk from a parking point in the Hurlingham to All…
7 years ago
Real estate down-under is a one-way bet
Well-off Aussies and Kiwis prefer to invest their hard-earned dollars in bricks and mortar. With home prices softening in the…
7 years ago
2 shares offering a bright income outlook
Interest rates in the UK have already started to rise. The Bank of England is now expected to increase them…
7 years ago